School of Medicine


Showing 81-100 of 156 Results

  • Irene L. Llorente

    Irene L. Llorente

    Assistant Professor of Neurosurgery

    BioOriginally from Spain, Irene L. Llorente joined the Neurosurgery Department at Stanford University in 2022. Following her undergraduate degree in Molecular Biology at the University of Leon in Spain, Dr. Llorente completed an MS in Molecular Biology and Biomedicine and a Ph.D. in Neuroscience between the Universities of Leon (Spain) and Florence (Italy). She conducted a postdoctoral fellowship in the Neurology Department at the David Geffen School of Medicine at UCLA where she also started her independent career as a Research Assistant Professor. Her research interests are largely directed toward understanding the biology of white matter repair in central nervous system disorders. She is particularly interested in leveraging the current technologies emerging in the stem cell field to develop more efficient and effective stem cell-based therapies for stroke, spinal cord injury, Traumatic brain injury, and vascular dementia patients.

  • Zhonglin Lyu

    Zhonglin Lyu

    Instructor, Neurosurgery

    BioDr. Lyu is an instructor at the Department of Neurosurgery, Stanford University School of Medicine. He obtained his PhD at Soochow University, China, where he gained training in designing biomaterials to modulate stem cell behaviors and led multidisciplinary research under the advice of Prof. Hong Chen. During his PhD, he worked as a visiting student researcher at Canary Center for Early Cancer Detection at Stanford University School of Medicine where he gained training in microfluidics and cancer metastasis. Dr. Lyu carried out his postdoctoral research under the guidance of Prof. Jon Park and Wonjae Lee at the Department of Neurosurgery, Stanford University School of Medicine. He developed an in vitro microphysiological model of ischaemic stroke and used it as a platform to systematically evaluate the restorative potential of stem cell therapy.
    As an instructor, Dr. Lyu's main research interest is to develop in vitro tissue/organ models to mimic human diseases including neurological diseases and cancer metastases. The goal is to use these models to understand disease mechanisms, to evaluate the safety and efficacy of existing drugs, and to look for new therapeutic targets.

  • Kelly Mahaney

    Kelly Mahaney

    Assistant Professor of Neurosurgery

    BioDr. Mahaney is a Pediatric Neurosurgeon with clinical interest in Hydrocephalus, Craniovertebral Junction abnormalities, Spasticity, Spinal dysraphism and Myelomeningocele, Central Nervous System tumors, and Pediatric Epilepsy surgery. She completed residency training at the University of Iowa Hospitals and Clinics and subspecialty Pediatric Neurosurgery training at The Hospital for Sick Children in Toronto and the Barrow Neurologic Institute at Phoenix Children's Hospital. She is interested in advancing Neuro-endoscopic techniques in Pediatric Neurosurgical practice. Dr. Mahaney's research focuses on delineating the role of iron in the development of post-hemorrhagic hydrocephalus.

  • Cormac Maher, MD, FAANS, FAAP, FACS

    Cormac Maher, MD, FAANS, FAAP, FACS

    Botha Chan Endowed Professor

    BioDr. Maher is a board-certified, fellowship-trained neurosurgeon with Stanford Health Care and is chief of neurosurgery at Lucile Packard Children’s Hospital Stanford. He is also the Botha Chan Endowed Professor in the Department of Neurosurgery, Division of Pediatric Neurosurgery at Stanford University School of Medicine.

    Dr. Maher specializes in treating children who have neurological disorders — conditions of the brain, spinal cord, and nerves. In his adult practice, he offers particular expertise in treating Chiari malformation, which involves a portion of the brain pushing down into the spinal canal, and tethered spinal cord. Dr. Maher has served on many national organization committees for research and training in neurosurgery.

    Dr. Maher has published more than 190 articles in peer-reviewed journals, including Journal of Neurosurgery, Neurosurgery, and Journal of Neurosurgery: Pediatrics. He has also served on the editorial boards for publications and organizations including the Journal of Neurosurgery Publishing Group. He has performed ad hoc review for many other journals and grant review for organizations including the American Association of Neurological Surgeons (AANS).

    Dr. Maher has delivered hundreds of presentations at symposiums and conferences for national and international audiences. He is also a fellow of the American Academy of Pediatrics, AANS, and American College of Surgeons.

  • Paul Salomon Mischel

    Paul Salomon Mischel

    Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.

  • Michelle Monje

    Michelle Monje

    Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.

  • Seema Nagpal, MD

    Seema Nagpal, MD

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsI'm a board certified neuro-oncologist who treats both primary brain tumors as well as metastatic disease to the brain and nervous system. My research concentrates on clinical trials for patients with late-stage central nervous system cancer. I have a special interest in leptomeningeal disease, a devastating complication of lung and breast cancers. I collaborate with Stanford scientists to detect this disease earlier, and with our breast and lung oncologists to improve outcomes for patients.

  • Jayakar V. Nayak, MD, PhD

    Jayakar V. Nayak, MD, PhD

    Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsUpper Airway Stem Cell Biology, Fate, and Repair/Regeneration of the Airway Epithelium to treat Upper and Lower Airway Disorders

  • Paul Nuyujukian

    Paul Nuyujukian

    Assistant Professor of Bioengineering and of Neurosurgery and, by courtesy, of Electrical Engineering

    Current Research and Scholarly InterestsOur group explores neuroengineering and its application to both basic and clinical neuroscience. Our goal is to develop brain-machine interfaces as a platform technology for a variety of brain-related medical conditions including stroke and epilepsy.

  • Thomas Osborne, MD

    Thomas Osborne, MD

    Adjunct Clinical Professor, Neurosurgery

    BioThomas Osborne, MD is board certified in Diagnostic Imaging and Neuroradiology.

    He has devoted his professional career to accelerating advancements at the intersection of healthcare, technology, and business. He is driven to solve challenges for broad positive impact and shared success.

    Dr. Osborne’s academic publications cover a diversity of topics such as cancer, infectious disease, neurologic disorders, surgery, pain and anxiety, climate health, falls, elder care, determinants of health, telehealth, diagnostics, predictive analytics, drug repurposing, cost savings, employee morale, strategy, efficiencies, health risk, safety, and the integration of advanced technologies into clinical practice.

    Dr. Osborne received his medical degree from Dartmouth Medical School and completed his clinical residency and fellowship at Harvard hospitals. He has been an advisor and mentor to other healthcare leaders for most of his career. He is also the Chief Medical Officer at Microsoft, Federal Civilian.

    LinkedIn: https://www.linkedin.com/in/tomosbornemd/
    Google Scholar: https://scholar.google.com/citations?hl=en&user=2v4Q8DoAAAAJ

  • Theo Palmer

    Theo Palmer

    Professor of Neurosurgery, Emeritus

    Current Research and Scholarly InterestsMembers of the Palmer Lab study the biology of neural stem cells in brain development and in the adult. Our primary goal is to understand how genes and environment synergize in influencing stem cell behavior during development and how mild genetic or environmental risk factors for disease may synergize in their detrimental effects on brain development or in the risk of neuronal loss in age-related degenerative disease.

  • David J. Park, MD, PhD, FCNS

    David J. Park, MD, PhD, FCNS

    Clinical Assistant Professor, Neurosurgery

    Current Research and Scholarly InterestsThe goal of our Laboratory is to improve patients’ care and outcomes by analyzing clinical data from thousands of patients treated at our institution. Our current primary areas of interest are benign tumors, brain and spine metastases, and neurogenetic disorders.
    Our lab is led by Dr. Steven D. Chang and Dr. David J. Park and proudly hosts talented young clinical scientists from around the world.
    Link: https://med.stanford.edu/neurosurgery/research/NeuroOncLab.html

  • Jon Park, MD, FRCSC

    Jon Park, MD, FRCSC

    Saunders Family Professor

    Current Research and Scholarly InterestsNon-fusion dynamic spinal stabilization, artificial disc technologies, and regenerative spinal technologies.

  • Sonia Partap

    Sonia Partap

    Clinical Professor, Pediatric Neurology
    Clinical Professor (By courtesy), Neurosurgery
    Clinical Professor, Pediatrics

    Current Research and Scholarly InterestsMy research interests involve the epidemiology, treatment and diagnosis of pediatric and young adult brain tumors. I am also interested in long-term neurologic effects and designing clinical trials to treat brain and spinal cord tumors.

  • Josef Parvizi, MD, PhD

    Josef Parvizi, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    BioDr. Parvizi completed his medical internship at Mayo Clinic, neurology training at Harvard, and subspecialty training in clinical neurophysiology and epilepsy at UCLA before joining the Department of Neurology and Neurological Sciences at Stanford in 2007. Dr. Parvizi directs the Stanford Program for Medication Resistant Epilepsies and specializes in surgical treatments of intractable focal epilepsies. Dr. Parvizi is the principal investigator in the Laboratory of Behavioral and Cognitive Neuroscience, where he leads a team of investigators to study the human brain. http://med.stanford.edu/parvizi-lab.html.

    Epilepsy patient story: https://www.youtube.com/watch?v=HXy-gXg0t94&t=3s